Did You Know Feb-Mar 2022 - Pharma Machines & Technology

DID YOU KNOW?

Lupin's orphan drug NaMuscla (mexiletine) for the symptomatic treatment of myotonia in adults with non- dystrophic myotonic (NDM) disorders is the first and only licensed product for this indication.
Non-dystrophic myotonic (NDM) disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction.
As per the World Malaria Report 2021, about 96% of malaria deaths globally were in 29 countries. India accounted for about 82% of all malaria deaths in the WHO South-East Asia Region
Globally, the market for laboratory products is estimated at Rs 24,000 crore and dominated by a few devel- oped countries.
Globally, rabies deaths are rarely reported and children between the ages of 5-14 years are frequent victims.
A global strategy on cholera control, Ending Cholera: a global roadmap to 2030, with a target to reduce cholera deaths by 90% was launched in 2017.
Globally, there are nearly 1.7 billion cases of childhood diarrhoeal disease every year. It is a leading cause of malnutrition in children under five years old.
In 2019, hepatitis B resulted in an estimated 820 000 deaths, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer).
Human papillomavirus (HPV), mainly transmitted through sexual contact, is a group of viruses that are extremely common worldwide.
Epidemics of meningitis, a devastating disease, are seen across the world, particularly in sub-Saharan Afric.
India's $9 billion diagnostics services sector is highly fragmented with less than 20% of the industry repre- sented by organised chains.
There are around 100,000 pathology labs in the country, of them only 2400 labs are accredited.
Micro Life Sciences Private Limited, parent organization of Meril group of companies, is India's largest medical devices company.
Russia and CIS countries are third largest revenue generating geography for Dr Reddy's after US and India.
Covaxin has already been granted Emergency Use Listing (EUL) in 13 countries as on January 31 according to the WHO.
Bacterial vaginosis is a common vaginal infection and trichomoniasis is the most common non-viral, curable sexually transmitted infection.
In January 2022, the antibiotic medicine Azithral, marketed by Alembic Pharma became the largest-selling pharma brand for the first time.